 |
|
|
| |
MODEL-BASED APPROACH OF DOSE SELECTION AND OPTIMAL PK SAMPLING OF FOSTEMSAVIR FOR PEDIATRIC PATIENTS WITH MULTIDRUG RESISTANT HIV-1 INFECTION
|
| |
| |
IAC 2020 July 6-10
Reported by Jules Levin
Nilay Thakkar,1 Mindy Magee,1 Katy Moore,2 Peter Ackerman,2 Shiven Chabria,2 Cyril Llamoso,2 Navin Goyal1
1GlaxoSmithKline, Clinical Pharmacology Modeling and Simulation, Collegeville, PA, USA; 2ViiV Healthcare, Research Triangle Park, NC, USA
|
| |
|
|
|
|
|
